Hutchin Hill Capital’s Zimmer Biomet ZBH Stock Holding History

Hutchin Hill Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-89,053	Closed	-$10.1M	–	737
2017 Q3	$10.1M	Buy	+89,053	New	+$10.3M	0.38%	73
2017 Q2	–	Sell	-30,900	Closed	-$3.66M	–	1074
2017 Q1	$3.66M	Sell	30,900 -48,410	-61%	-$5.49M	0.1%	223
2016 Q4	$7.95M	Buy	79,310 +73,233	+1,205%	+$7.85M	0.27%	82
2016 Q3	$767K	Buy	+6,077	New	+$751K	0.02%	414
2014 Q2	–	Sell	-24,823	Closed	-$2.28M	–	757
2014 Q1	$2.28M	Buy	+24,823	New	+$2.29M	0.12%	159

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hutchin Hill Capital's ZBH Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 89,053 shares — an estimated $10.1M sold.

Hutchin Hill Capital first reported a position in ZBH in Q1 2014 and held it in 5 quarters. The position peaked at $10.1M in Q3 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

Hutchin Hill Capital reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
Hutchin Hill Capital sold 89,053 Zimmer Biomet shares in Q4 2017, an estimated $10.1M.
Hutchin Hill Capital first reported a position in Zimmer Biomet in Q1 2014 and held it in 5 quarters.
Hutchin Hill Capital's Zimmer Biomet position peaked at $10.1M in Q3 2017.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.